VYNT - Vyant Bio GAAP EPS of -$0.20 revenue of $0.17M August, 22 2022 04:12 PM Vyant Bio Inc. Vyant Bio press release ( NASDAQ: VYNT ): Q2 GAAP EPS of -$0.20. Revenue of $0.17M (-48.5% Y/Y). Cash and cash equivalents totaled $11.7M as of June 30, 2022. For further details see: Vyant Bio GAAP EPS of -$0.20, revenue of $0.17M